Published in Skeletal Radiol on May 25, 2004
Presumed osteosarcoma. Clin Kidney J (2013) 0.75
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81
Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol (2002) 2.55
Teriparatide: a novel agent that builds new bone. J Am Pharm Assoc (2003) (2003) 1.38
Recombinant human parathyroid hormone. BMJ (2002) 1.06
Osteosarcoma of bone in apatient with primary hyperparathyroidism: a case report. J Bone Miner Res (2003) 0.83
Hyperparathyroidism associated with sarcoma of bone. Skeletal Radiol (1997) 0.81
Osteosarcoma risk in rats using PTH 1-34. Trends Endocrinol Metab (2001) 0.80
Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed. BMJ (2002) 0.75
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol (2004) 4.46
Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am (2011) 3.23
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer (2006) 3.11
Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev (2006) 2.85
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol (2012) 2.67
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol (2005) 2.17
Gigantic methameric seborrheic keratosis. Plast Reconstr Surg (2002) 2.05
Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Pediatr Hematol Oncol (2003) 1.99
Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol (2005) 1.94
Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev (2009) 1.89
Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol (2003) 1.79
Evolution of surgical treatment for sarcomas of proximal humerus in children: retrospective review at a single institute over 30 years. J Pediatr Orthop (2010) 1.69
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer (2004) 1.65
Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials (2003) 1.61
NVP-BEZ235 as a new therapeutic option for sarcomas. Clin Cancer Res (2010) 1.52
Clinically significant thromboembolic disease in orthopedic oncology: an analysis of 986 patients treated with low-molecular-weight heparin. J Surg Oncol (2010) 1.45
Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 de novo cases. Radiographics (2004) 1.44
Primary angiosarcoma of the parotid gland arising from benign congenital hemangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.40
Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch (2009) 1.39
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol (2007) 1.36
The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol (2002) 1.35
Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori (2007) 1.31
Imaging findings in desmoplastic fibroma of bone: distinctive T2 characteristics. AJR Am J Roentgenol (2005) 1.29
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol (2009) 1.28
Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res (2010) 1.26
Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. Cancer (2009) 1.26
Allograft-prosthetic composite in the proximal tibia after bone tumor resection. Clin Orthop Relat Res (2008) 1.26
Percutaneous CT-guided biopsy of the spine: results of 430 biopsies. Eur Spine J (2008) 1.22
High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005. Surg Oncol (2009) 1.20
Selective arterial embolization of 36 aneurysmal bone cysts of the skeleton with N-2-butyl cyanoacrylate. Skeletal Radiol (2010) 1.20
Proximal femur reconstruction by an allograft prosthesis composite. Clin Orthop Relat Res (2002) 1.20
The use of cement in osteoarticular allografts for proximal humeral bone tumors. Clin Orthop Relat Res (2004) 1.19
Local recurrence, survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas. Clin Orthop Relat Res (2010) 1.18
Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol (2006) 1.17
Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors. J Bone Joint Surg Am (2011) 1.17
Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer (2005) 1.16
Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res (2005) 1.16
Imaging of vascularized fibula autograft placed inside a massive allograft in reconstruction of lower limb bone tumors. AJR Am J Roentgenol (2004) 1.14
Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol (2010) 1.14
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer (2010) 1.13
Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol (2010) 1.12
Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer (2005) 1.10
Distinct histological features characterize primary angiosarcoma of bone. Histopathology (2011) 1.10
Sternal reconstruction with synthetic mesh and metallic plates for high grade tumours of the chest wall. Eur J Surg (2002) 1.09
Dedifferentiated central chondrosarcoma. Cancer (2006) 1.08
Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol (2009) 1.07
Primary high-grade osteosarcoma: comparison between preadolescent and older patients. J Pediatr Hematol Oncol (2005) 1.06
Clear cell chondrosarcoma of bone: long time follow-up of 18 cases. Arch Orthop Trauma Surg (2007) 1.06
Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res (2009) 1.06
Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II. Int J Radiat Oncol Biol Phys (2004) 1.05
Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Rep (2003) 1.02
Late relapse in osteosarcoma. J Pediatr Hematol Oncol (2006) 1.02
Xanthoma of bone: first sign of hyperlipidemia type IIB: a case report. Clin Orthop Relat Res (2003) 1.02
Quality of life following limb-salvage surgery for bone sarcomas. Expert Rev Pharmacoecon Outcomes Res (2011) 1.01
Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma. Pathol Res Pract (2006) 1.01
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. Eur J Cancer (2005) 1.01
Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. J Pediatr Hematol Oncol (2005) 1.00
Original biological reconstruction of the hip in a 4-year-old girl. Lancet (2003) 1.00
Protocol of surgical treatment of long bone pathological fractures. Injury (2010) 1.00
Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years. Acta Orthop Scand (2004) 0.99
Dedifferentiated chondrosarcomas arising in preexisting osteochondromas. J Bone Joint Surg Am (2007) 0.98
Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006). Cancer (2012) 0.97
Aggressive clear cell chondrosarcomas: do distinctive characteristics exist?: a report of 4 cases. Arch Pathol Lab Med (2006) 0.96
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. J Nucl Med (2010) 0.96
Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation. AJNR Am J Neuroradiol (2003) 0.96
Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol (2007) 0.96
Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Cancer (2004) 0.96
Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol (2005) 0.95
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol (2003) 0.95
The use of prolonged peripheral neural blockade after lower extremity amputation: the effect on symptoms associated with phantom limb syndrome. Anesth Analg (2010) 0.94
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol (2008) 0.94
Long-term results in children with massive bone osteoarticular allografts of the knee for high-grade osteosarcoma. J Pediatr Orthop (2010) 0.94
Outcome of the intramedullary diaphyseal segmental defect fixation system for bone tumors. J Surg Oncol (2011) 0.94
Chondrosarcoma of the chest wall: a clinical analysis. Surg Today (2002) 0.94
Primary schwannoma of the bone: a clinicopathologic and radiologic study of 17 cases. Am J Surg Pathol (2011) 0.93
Prognostic factors in Ewing's sarcoma of the foot. Clin Orthop Relat Res (2004) 0.92
Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor. Clin Orthop Relat Res (2010) 0.92
Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene (2006) 0.92